IPA downregulates matrix metalloproteinase-13 activity, which prevents cartilage destruction and increases eNOS activity and NO production, thereby inhibiting tumor necrosis factor alpha (TNF-α)-induced endothelial dysfunction [24,25]. Here, TNF is linked to endothelial dysfunction.